List of Contents

Women’s Health Devices Market Size, Share, and Trends 2024 to 2034

Women’s Health Devices Market (By Application: Chronic Diseases, General Health, Reproductive Health, Pelvic & Uterine Health, Others; By End Users: Hospitals & Clinics, Home Healthcare, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032

  • Last Updated : October 2023
  • Report Code : 1492
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Women’s Health Devices Market 

5.1. COVID-19 Landscape: Women’s Health Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Women’s Health Devices Market, By Product

8.1. Women’s Health Devices Market, by Product Type, 2023-2032

8.1.1. Surgical

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Diagnostics

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Contraceptives

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Labor & Delivery

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Critical Care

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Women’s Health Devices Market, By Type

9.1. Women’s Health Devices Market, by Type, 2023-2032

9.1.1. Devices

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Consumables

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Women’s Health Devices Market, By Application Type 

10.1. Women’s Health Devices Market, by Application Type, 2023-2032

10.1.1. Chronic Diseases

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. General Health

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Reproductive Health

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Pelvic & Uterine Health

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Cancer

10.1.5.1. Market Revenue and Forecast (2020-2032)

10.1.6. Infectious Disease

10.1.6.1. Market Revenue and Forecast (2020-2032)

10.1.7. Uterine Fibroids

10.1.7.1. Market Revenue and Forecast (2020-2032)

10.1.8. Others

10.1.8.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Women’s Health Devices Market, By End User Type 

11.1. Women’s Health Devices Market, by End User Type, 2023-2032

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Home Healthcare

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Obstetrics & Gynecology Clinics

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Diagnostic Laboratories

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Ambulatory Surgical Centers

11.1.5.1. Market Revenue and Forecast (2020-2032)

11.1.6. Others

11.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Women’s Health Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Type (2020-2032)

12.1.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End User Type (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End User Type (2020-2032)

Chapter 13. Company Profiles

13.1. GE Healthcare

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. F. Hoffmann-La Roche

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Hologic

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Koninklijke Philips

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Siemens AG

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Prestige Consumer Healthcare, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Abbott Laboratories

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Caldera Medical

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. MedGyn Products

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Medline Industries

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. Carestream Health

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global women’s health devices market size was worth at US$ 31 billion in 2022 and is projected to reach over US$ 70.41 billion by 2032.

The global women’s health devices market is expected to grow at a CAGR of 8.60% from 2023 to 2032.

The rising prevalence of chronic diseases among the women population, rising awareness regarding the women healthcare, increasing adoption of advanced healthcare devices, and rising focus of the manufacturers pertaining to women’s healthcare are the prominent factors responsible for the growth of the global women’s health devices market.

The major players operating in the women’s health devices market are GE Healthcare, F. Hoffmann-La Roche, Hologic, Koninklijke Philips, Siemens AG, Prestige Consumer Healthcare, Inc., Abbott Laboratories, Caldera Medical, MedGyn Products, Medline Industries, Carestream Health.

North America dominated the global women’s health devices market, garnering a market share of around 32% in 2022. This is attributed to the increased awareness and higher adoption of the women’s health devices like medical implants and self-diagnostic devices.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
* Immediate Delivery Available *

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us